RxDoctor Payments Data

Danny Fox, MD

Family Medicine · Oldsmar, FLNPI 1568416816

Payments from drug & device makers

$1,635in general payments, 2019–2025

Across 108 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$316
  • AstraZeneca$231
  • Pfizer$213
  • Takeda Pharmaceuticals U.S.A., Inc.$177
  • AbbVie$105
  • Lilly USA, LLC$94
  • plus $499 from 9 others

What the payments were for

  • Food & beverage$1,635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,635 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$88,257
Medicare patients
219
Services billed
1,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin44$54,894
EliquisApixaban30$35,611
TrulicityDulaglutide26$31,020
OzempicSemaglutide29$27,348
XareltoRivaroxaban16$22,055
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,925
JanuviaSitagliptin Phosphate11$12,391
Janumet XrSitagliptin Phos/Metformin Hcl11$11,217
Tresiba Flextouch U-100Insulin Degludec16$5,814
Colesevelam Hcl35$4,973
Naproxen14$3,325
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$3,159
Atorvastatin Calcium282$2,664
Levothyroxine Sodium266$2,430
Omeprazole109$2,301

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$91$54,89444 claims
PfizerEliquis$213$35,61130 claims
Lilly USA, LLCTrulicity$94$31,02026 claims
Novo NordiskOzempic$316$27,34829 claims
MerckJanuvia, Janumet Xr$75$23,60822 claims
GSKTrelegy Ellipta, Anoro Ellipta$62$19,08429 claims
AbbVieSynthroid$105$2,28123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Oldsmar

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →